Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Karl Kelsey
Columbia University Health Sciences, Department: Pediatrics
Should you be removed from our database? Contact us at [email protected]. Read more below.
Celintec
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Please see the attached summary.
Methylation and mutations in RB1 and variants of synthetic folic acid metabolism
Prior work in our cohort of children with retinoblastoma suggests that women homozygous for DHFR19bpdel are at increased risk to have a child with retinoblastoma, particularly when taking prenatal folic acid supplements. We will examine how maternal and child DHFR and folic acid intake may be associated with methylation and associated mutations in retinoblastoma tumor DNA. Retinoblastoma offers us a unique model for examining how folic acid may affect carcinogenesis, of particularly significance given that other studies suggest that elevated folic acid intake may contribute to carcinogenesis in breast, colon and lung cancer
Filed on September 13, 2018.
Tell us what you know about Karl Kelsey's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Karl Kelsey”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Karl Kelsey | University of California, San Francisco | Conflict of Interest | Cellintec | $0 - $4,999 |
| Karl Kelsey | Tufts University Boston | Conflict of Interest | Celintec | Value cannot be readily determined |
| Karl Kelsey | Dartmouth College | Conflict of Interest | Celintec | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.